FDA 483 - ALI Pharmaceutical Manufacturing LLC - October 03, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
ALJ Pharmaceutical Manufacturing, LLC in Omaha, NE, a drug substance manufacturer, received a Form 483 with four observations. The inspection revealed significant deficiencies in process validation, microbiological specifications, investigation procedures for deviations and out-of-specification results, and quality unit responsibilities. These issues indicate a lack of scientific soundness and control over manufacturing processes, potentially impacting product quality and purity.
ID · dd111a0f-1896-4c7d-aea0-dbd4f3efc866